A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients
Clinical trial NCT00384137 · COMPLETED
Trial details
- NCT number
- NCT00384137
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-07-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.